Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03618134
Title Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Jonsson Comprehensive Cancer Center
Indications

oral squamous cell carcinoma

pharynx squamous cell carcinoma

Therapies

Durvalumab

Durvalumab + Tremelimumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST